| CVP chemotherapy plus rituximab compared with CVP as first-line treatment for advanced follicular lymphoma R Marcus, K Imrie, A Belch, D Cunningham, E Flores, J Catalano, ... Blood 105 (4), 1417-1423, 2005 | 1236 | 2005 |
| Sotagliflozin in patients with diabetes and chronic kidney disease DL Bhatt, M Szarek, B Pitt, CP Cannon, LA Leiter, DK McGuire, JB Lewis, ... New England Journal of Medicine 384 (2), 129-139, 2021 | 848 | 2021 |
| CKD prevalence varies across the European general population K Brück, VS Stel, G Gambaro, S Hallan, H Völzke, J Ärnlöv, M Kastarinen, ... Journal of the American Society of Nephrology 27 (7), 2135-2147, 2016 | 659 | 2016 |
| First diabetes prevalence study in Portugal: PREVADIAB study L Gardete‐Correia, JM Boavida, JF Raposo, AC Mesquita, C Fona, ... Diabetic Medicine 27 (8), 879-881, 2010 | 283 | 2010 |
| Frontline rituximab, cyclophosphamide, doxorubicin, and prednisone with bortezomib (VR-CAP) or vincristine (R-CHOP) for non-GCB DLBCL F Offner, O Samoilova, E Osmanov, HS Eom, MS Topp, J Raposo, ... Blood, The Journal of the American Society of Hematology 126 (16), 1893-1901, 2015 | 145 | 2015 |
| Review of methods for detecting glycemic disorders M Bergman, M Abdul-Ghani, RA DeFronzo, M Manco, G Sesti, ... Diabetes research and clinical practice 165, 108233, 2020 | 130 | 2020 |
| Diabetes: Factos e Números 2011− Relatório Anual do Observatório Nacional da Diabetes JM Boavida, JP Fragoso de Almeida, S Massano Cardoso, ... Lisboa: Sociedade Portuguesa de Diabetologia, 2012 | 123 | 2012 |
| Methodology used in studies reporting chronic kidney disease prevalence: a systematic literature review K Brück, KJ Jager, E Dounousi, A Kainz, D Nitsch, J Ärnlöv, ... Nephrology Dialysis Transplantation 30 (suppl_4), iv6-iv16, 2015 | 113 | 2015 |
| Hepatic glutathione and nitric oxide are critical for hepatic insulin-sensitizing substance action MP Guarino, RA Afonso, N Raimundo, JF Raposo, MP Macedo American Journal of Physiology-Gastrointestinal and Liver Physiology 284 (4 …, 2003 | 110 | 2003 |
| HbA1c, fructosamine, and glycated albumin in the detection of dysglycaemic conditions R Tavares Ribeiro, M Paula Macedo, J Filipe Raposo Current Diabetes Reviews 12 (1), 14-19, 2016 | 94 | 2016 |
| A minimal mathematical model of calcium homeostasis JF Raposo, LG Sobrinho, HG Ferreira The Journal of Clinical Endocrinology & Metabolism 87 (9), 4330-4340, 2002 | 92 | 2002 |
| Rituximab plus bendamustine or chlorambucil for chronic lymphocytic leukemia: primary analysis of the randomized, open-label MABLE study AS Michallet, M Aktan, W Hiddemann, O Ilhan, P Johansson, K Laribi, ... haematologica 103 (4), 698, 2018 | 83 | 2018 |
| A standard set of person‐centred outcomes for diabetes mellitus: results of an international and unified approach J Nano, F Carinci, O Okunade, S Whittaker, M Walbaum, K Barnard‐Kelly, ... Diabetic Medicine 37 (12), 2009-2018, 2020 | 79 | 2020 |
| The association between polypharmacy and adverse health consequences in elderly type 2 diabetes mellitus patients; a systematic review and meta-analysis ALM Labib, AP Martins, JF Raposo, C Torre Diabetes Research and Clinical Practice 155, 107804, 2019 | 72 | 2019 |
| Diabetes hinders community-acquired pneumonia outcomes in hospitalized patients M Martins, JM Boavida, JF Raposo, F Froes, B Nunes, RT Ribeiro, ... BMJ Open Diabetes Research and Care 4 (1), e000181, 2016 | 65 | 2016 |
| Effects of combined training with different intensities on vascular health in patients with type 2 diabetes: a 1-year randomized controlled trial JP Magalhães, X Melo, IR Correia, RT Ribeiro, J Raposo, H Dores, ... Cardiovascular diabetology 18, 1-13, 2019 | 64 | 2019 |
| First diabetic retinopathy prevalence study in Portugal: RETINODIAB Study—Evaluation of the screening programme for Lisbon and Tagus Valley region MD Medeiros, E Mesquita, AL Papoila, V Genro, JF Raposo British Journal of Ophthalmology 99 (10), 1328-1333, 2015 | 59 | 2015 |
| ADA/EASD R Duarte, M Melo, JS Nunes, PC Melo, JF Raposo, D Carvalho, A Jordão, ... Revista Portuguesa de Diabetes 13 (4), 154-180, 2018 | 58 | 2018 |
| Possibilities and challenges of a large international benchmarking in pediatric diabetology—the SWEET experience M Witsch, I Kosteria, O Kordonouri, G Alonso, M Archinkova, S Besancon, ... Pediatric diabetes 17, 7-15, 2016 | 55 | 2016 |
| Vulnerability to stress, anxiety and depressive symptoms and metabolic control in type 2 diabetes C Gois, VV Dias, JF Raposo, I do Carmo, A Barbosa BMC research notes 5, 1-6, 2012 | 51 | 2012 |
